ECAT (ECAT) Stock Price & Analysis
ECAT (ECAT) rose 0.07% to USD 15.33 as of June 9, 2026 at 23:41 UTC, according to Nexqual real-time market data.
ECAT last closed at USD 15.32; the session ranged USD 15.09–15.48 on volume of 467,065 shares. Market capitalization is $1.52B, with a 52-week range of USD 13.36–17.14 (NYQ). Source: Nexqual, June 9, 2026 at 23:41 UTC.
Key Statistics (as of June 9, 2026 at 23:41 UTC)
| Price | USD 15.33 |
|---|---|
| Change | ▲ 0.07% (up) |
| Previous Close | USD 15.32 |
| Open | USD 15.31 |
| Day Range | USD 15.09 – 15.48 |
| 52-Week Range | USD 13.36 – 17.14 |
| Volume | 467,065 shares |
| Market Cap | $1.52B |
| Exchange | NYQ |
Technical Analysis (ECAT)
Nexqual's technical model rates ECAT "NEUTRAL" based on 3 bullish and 2 bearish signals across 124 daily candles, as of June 9, 2026 at 23:41 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 53.53 (neutral) |
| vs SMA50 | Above (USD 14.93) |
| MACD | 0.15 (positive) |
Analyst Ratings (ECAT)
Wall Street analysts rate ECAT "None", per Nexqual as of June 9, 2026 at 23:41 UTC.
| Consensus Rating | None |
|---|
Earnings (ECAT)
Source: Nexqual, June 9, 2026 at 23:41 UTC.
Financials & Fundamentals (ECAT)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
Source: Nexqual, June 9, 2026 at 23:41 UTC.
Financial Health Score (ECAT)
Nexqual rates ECAT's overall financial health "Mixed" across five dimensions, as of June 9, 2026 at 23:41 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Ownership (ECAT)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +34.15% |
| Shares Outstanding | 99.47M |
| Short % of Float | +0.36% |
Source: Nexqual, June 9, 2026 at 23:41 UTC.
Leadership (ECAT)
ECAT is led by John M. Perlowski (age 61), President, CEO, CFO, Treasurer, Secretary & Trustee, per Nexqual as of June 9, 2026 at 23:41 UTC.
| President, CEO, CFO, Treasurer, Secretary & Trustee | John M. Perlowski (age 61) |
|---|
Major Backers & Investors (ECAT)
Notable institutional backers of ECAT include Saba Capital Management, L.P., Morgan Stanley, Invesco, according to Nexqual as of June 9, 2026 at 23:41 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Saba Capital Management, L.P. | 22.14% |
| Morgan Stanley | 2.22% |
| Invesco | 2.04% |
| Exchange Listed Funds Trust-Saba Closed-End Funds ETF | 1.87% |
| Cohen & Steers Inc. | 1.74% |
| Penserra Capital Management LLC | 1.47% |
| Amplify ETF Trust-Amplify CEF High Income ETF | 1.46% |
| Royal Bank of Canada | 1.23% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 1.24% |
Source: Nexqual, June 9, 2026 at 23:41 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BCAT | BlackRock Capital Allocation Term Trust | USD 15.6 | ▲ 0.91% |
| BMEZ | BlackRock Health Sciences Trust | USD 14.29 | ▼ 0.28% |
| WDI | Western Asset Diversified Income Fund | USD 13.21 | ▼ 0.08% |
| BSTZ | BlackRock Science and Technolog | USD 29.23 | ▲ 0.62% |
| NBXG | Neuberger Berman Income Funds - Neuberger Next Generation Connectivity Fund Inc. | USD 15.9 | ▼ 0.06% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:41 UTC. This page is informational and not investment advice.